Literature DB >> 23905533

Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma.

Louise Fleming, Lemonia Tsartsali, Nicola Wilson, Nicolas Regamey, Andrew Bush.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23905533      PMCID： PMC3778731          DOI： 10.1164/rccm.201212-2156LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  16 in total

1.  Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma.

Authors:  Parameswaran Nair; Melanie Kjarsgaard; Susan Armstrong; Ann Efthimiadis; Paul M O'Byrne; Frederick E Hargreave
Journal:  J Allergy Clin Immunol       Date:  2010-08       Impact factor: 10.793

2.  ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-04-15       Impact factor: 21.405

3.  Use of sputum eosinophil counts to guide management in children with severe asthma.

Authors:  Louise Fleming; Nicola Wilson; Nicolas Regamey; Andrew Bush
Journal:  Thorax       Date:  2011-08-08       Impact factor: 9.139

4.  NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response.

Authors:  R A Dweik; S A Comhair; B Gaston; F B Thunnissen; C Farver; M J Thomassen; M Kavuru; J Hammel; H M Abu-Soud; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

5.  Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study.

Authors:  Martha Scott; Abid Raza; Wilfried Karmaus; Frances Mitchell; Jane Grundy; Ramesh J Kurukulaaratchy; S Hasan Arshad; Graham Roberts
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

6.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.

Authors:  E Pizzichini; M M Pizzichini; A Efthimiadis; S Evans; M M Morris; D Squillace; G J Gleich; J Dolovich; F E Hargreave
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

7.  Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern.

Authors:  Christiane Lex; Donald N R Payne; Angela Zacharasiewicz; Albert M Li; Nicola M Wilson; Trevor T Hansel; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2005-04

8.  Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.

Authors:  A Jatakanon; S Lim; S A Kharitonov; K F Chung; P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

9.  Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children.

Authors:  P J Franklin; S W Turner; P N Le Souëf; S M Stick
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

10.  Sputum inflammatory phenotypes are not stable in children with asthma.

Authors:  Louise Fleming; Lemonia Tsartsali; Nicola Wilson; Nicolas Regamey; Andrew Bush
Journal:  Thorax       Date:  2012-02-29       Impact factor: 9.139
View more
  13 in total

Review 1.  Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment?

Authors:  Anne M Fitzpatrick; Wendy C Moore
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Jul - Aug

2.  Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma.

Authors:  W Gerald Teague; Monica G Lawrence; Debbie-Ann T Shirley; Andrea S Garrod; Stephen V Early; Jackie B Payne; Julia A Wisniewski; Peter W Heymann; James J Daniero; John W Steinke; Deborah K Froh; Thomas J Braciale; Michael Ellwood; Drew Harris; Larry Borish
Journal:  J Allergy Clin Immunol Pract       Date:  2019-01-14

3.  Biomarker-based asthma phenotypes of corticosteroid response.

Authors:  Douglas C Cowan; D Robin Taylor; Laura E Peterson; Jan O Cowan; Rochelle Palmay; Avis Williamson; Jef Hammel; Serpil C Erzurum; Stanley L Hazen; Suzy A A Comhair
Journal:  J Allergy Clin Immunol       Date:  2014-12-06       Impact factor: 10.793

4.  Inducible Nitric Oxide Synthase Promoter Haplotypes and Residential Traffic-Related Air Pollution Jointly Influence Exhaled Nitric Oxide Level in Children.

Authors:  Muhammad T Salam; Pi-Chu Lin; Sandrah P Eckel; W James Gauderman; Frank D Gilliland
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

Review 5.  The Role of FeNO in Predicting Asthma.

Authors:  Mariëlle W Pijnenburg
Journal:  Front Pediatr       Date:  2019-02-21       Impact factor: 3.418

Review 6.  Which Child with Asthma is a Candidate for Biological Therapies?

Authors:  Andrew Bush
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 7.  Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD.

Authors:  Steve W Turner; Anne B Chang; Ian A Yang
Journal:  Breathe (Sheff)       Date:  2019-12

Review 8.  Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease.

Authors:  Andrew Bush; Ian D Pavord
Journal:  Breathe (Sheff)       Date:  2021-09

9.  Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Sumita B Khatri; Jonathan M Iaccarino; Amisha Barochia; Israa Soghier; Praveen Akuthota; Anna Brady; Ronina A Covar; Jason S Debley; Zuzana Diamant; Anne M Fitzpatrick; David A Kaminsky; Nicholas J Kenyon; Sandhya Khurana; Brian J Lipworth; Kevin McCarthy; Michael Peters; Loretta G Que; Kristie R Ross; Elena K Schneider-Futschik; Christine A Sorkness; Teal S Hallstrand
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 21.405

Review 10.  Approaches to Asthma Diagnosis in Children and Adults.

Authors:  Sejal Saglani; Andrew N Menzie-Gow
Journal:  Front Pediatr       Date:  2019-04-17       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.